+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Attention Deficit Hyperactivity Disorder Drug"

From
Attention Deficit Hyperactivity Disorder Market Report 2026 - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
From
From
From
From
Atomoxetine Hydrochloride Market - Global Forecast 2026-2032 - Product Thumbnail Image

Atomoxetine Hydrochloride Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 187 Pages
  • Global
From
Clonidine Market - Global Forecast 2026-2032 - Product Thumbnail Image

Clonidine Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 181 Pages
  • Global
From
From
From
From
From
Behavioral Health Market in the US 2026-2030 - Product Thumbnail Image

Behavioral Health Market in the US 2026-2030

  • Report
  • August 2026
  • 202 Pages
  • United States
From
From
Loading Indicator

Attention Deficit Hyperactivity Disorder (ADHD) is a mental disorder that affects a person's ability to focus and control their behavior. Mental Disorders Drugs are used to treat the symptoms of ADHD, such as difficulty concentrating, impulsivity, and hyperactivity. Stimulant medications are the most commonly prescribed drugs for ADHD, and they work by increasing the levels of dopamine and norepinephrine in the brain. Non-stimulant medications, such as atomoxetine, are also used to treat ADHD. The ADHD Drug market is highly competitive, with a number of pharmaceutical companies offering various medications. Companies such as Eli Lilly, Shire, Novartis, and Pfizer are some of the major players in the market. Other companies such as Teva Pharmaceuticals, Sun Pharmaceuticals, and Mylan also offer ADHD medications. These companies are constantly innovating and developing new drugs to meet the needs of patients with ADHD. Show Less Read more